UAVS: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Dollar

Cash Flow	2025-09-30	2025-06-30
Net income (loss)	3,164,500	5,779,663
Stock-based compensation	311,690	161,710
Depreciation and amortization	816,538	574,002
Loss on disposal of fixed assets	0	0
Interest added to convertible note payable	0	-35,265
Interest expense for reduction in convertible note conversion price	0	0
Defined benefit plan obligation	0	0
Amortization of debt discount and warrant modification	35,265	0
Fair value adjustment of warrants	-8,511,000	-8,506,000
Loss on debt extinguishment	-125,242	-125,242
Accounts receivable, net	951,818	903,472
Inventories, net	742,773	384,090
Prepaid expenses and other assets	-345,081	-454,235
Accounts payable	-2,100,335	-1,657,616
Accrued expenses and other liabilities	265,001	335,852
Contract liabilities	-92,493	-54,476
Other	0	0
Net cash used in operating activities	-7,335,102	-4,039,685
Purchases of property and equipment	38,338	23,882
Proceeds of sales of asset	0	-
Capitalization of internal use software costs	0	0
Net cash used in investing activities	-38,338	-23,882
Proceeds from exercise of warrants-Series BWarrants	8,317,002	1,790,516
Proceeds from the sale of series f preferred stock and warrants	8,800,000	4,500,000
Proceeds from exercise of warrants-Series FWarrants	3,804,318	0
Repayments on covid loans-Covid Loan	254,885	162,770
Payment to convertible note	0	0
Proceeds (repayments) on other short-term loans	-135,000	-135,000
Issuance costs for sale of series f preferred stock and warrants	146,971	47,000
Net cash provided by financing activities	20,384,464	5,945,746
Effects of foreign exchange rates on cash flows	3,538	6,409
Net change in cash	13,014,562	1,888,588
Cash and cash equivalents at beginning of period	3,613,996	-
Cash and cash equivalents at end of period	16,628,558	-

Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

UAVS: the cashflow